Ceribell, Inc. announced on September 22, 2025, the appointment of Erica Rogers to its Board of Directors. Ms. Rogers brings over three decades of experience in leading high-growth, innovative medical device companies to Ceribell's Board.
Ms. Rogers most recently served as Chief Executive Officer of Silk Road Medical, Inc., where she led the company from its early stages through FDA approval and broad commercial expansion, culminating in its acquisition by Boston Scientific Corporation. Under her leadership, Silk Road Medical grew from a 25-person startup to a 500-employee, publicly-traded company with revenue exceeding $175 million.
Her expertise in scaling healthcare companies and driving the adoption of new technologies in clinical practice will be invaluable as Ceribell works to expand nationwide access to its point-of-care EEG system. This appointment strengthens the company's governance and strategic guidance during a pivotal growth phase.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.